 Connection
Sarah Rhoads to Humans
This is a "connection" page, showing publications Sarah Rhoads has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.173 |
|
|
|
-
Rhoads SL, Seluk L, Wechsler ME. Asthma therapeutics: Past, present, and future. Pharmacol Rev. 2025 07; 77(4):100062.
Score: 0.022
-
Rhoads SL, Seluk L, Daryani B, Garrison J, Bonaccorsi P, Hosking P, Taylor JA, Wechsler ME. Assessment of Asthma Severity Using Remote Sensors: A Pilot Study. J Allergy Clin Immunol Pract. 2025 Jul; 13(7):1786-1792.
Score: 0.022
-
Rhoads SL, Mohan A. A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma. Chest. 2024 08; 166(2):241-242.
Score: 0.021
-
Rhoads SL, Edinger J, Khatiwada A, Zimmer J, Zelarney P, Wechsler ME. The impact of insomnia and depression on asthma control. J Asthma. 2024 10; 61(10):1248-1251.
Score: 0.020
-
Rhoads S, Auth R, Chambers A, Blundin M, Mahoney L, McLaughlin S, Banerjee D. Perceptions and Use of E-cigarettes among Young Adults with Cystic Fibrosis: An Observational Study. R I Med J (2013). 2023 08 01; 106(7):58-63.
Score: 0.019
-
Rhoads S, Cooney K, Banerjee D. Emotional Impact of COVID-19 Pandemic on Adults with Cystic Fibrosis. R I Med J (2013). 2021 12 01; 104(10):53-55.
Score: 0.017
-
Rhoads S, Amass T. Communication at the End-of-Life in the Intensive Care Unit: A Review of Evidence-Based Best Practices. R I Med J (2013). 2019 Dec 02; 102(10):30-33.
Score: 0.015
-
Davis AE, Rhoads S, Wechsler ME. Emerging biologic targets in type 2 and non-type 2 asthma. Curr Opin Pulm Med. 2026 May 01; 32(3):210-219.
Score: 0.006
-
Eggert L, Rhoads S, Wechsler ME, Akuthota P. Con: clinical remission in asthma - not yet there. Eur Respir Rev. 2025 Apr; 34(176).
Score: 0.005
-
Auth R, Rhoads S, Blundin M, Dziok A, Caddick-Dowty S, Banerjee D. Improving Inpatient Cystic Fibrosis Exacerbation Care: A Resident Physician Training Approach. R I Med J (2013). 2025 Apr 01; 108(4):26-31.
Score: 0.005
-
Seluk L, Davis AE, Rhoads S, Wechsler ME. Novel asthma treatments: Advancing beyond approved novel step-up therapies for asthma. Ann Allergy Asthma Immunol. 2025 01; 134(1):9-18.
Score: 0.005
-
Lugogo NL, Mohan A, Akuthota P, Couillard S, Rhoads S, Wechsler ME. Are We Ready for Asthma Remission as a Clinical Outcome? Chest. 2023 10; 164(4):831-834.
Score: 0.005
-
Ambler M, Rhoads S, Peterson R, Jin Y, Armstrong P, Collier P, Cruse MH, Csikesz N, Hua M, Engelberg RA, Halvorson K, Heywood J, Lee M, Likosky K, Mayer M, McGuirl D, Moss M, Nielsen E, Rea O, Tong W, Wykowski J, Yu S, Stapleton RD, Curtis JR, Amass T. One Year Later: Family Members of Patients with COVID-19 Experience Persistent Symptoms of Posttraumatic Stress Disorder. Ann Am Thorac Soc. 2023 05; 20(5):713-720.
Score: 0.005
-
Amass T, Van Scoy LJ, Hua M, Ambler M, Armstrong P, Baldwin MR, Bernacki R, Burhani MD, Chiurco J, Cooper Z, Cruse H, Csikesz N, Engelberg RA, Fonseca LD, Halvorson K, Hammer R, Heywood J, Duda SH, Huang J, Jin Y, Johnson L, Tabata-Kelly M, Kerr E, Lane T, Lee M, Likosky K, McGuirl D, Milinic T, Moss M, Nielsen E, Peterson R, Puckey SJ, Rea O, Rhoads S, Sheu C, Tong W, Witt PD, Wykowski J, Yu S, Stapleton RD, Curtis JR. Stress-Related Disorders of Family Members of Patients Admitted to the Intensive Care Unit With COVID-19. JAMA Intern Med. 2022 06 01; 182(6):624-633.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|